Prodia (PRDA IJ) - Diagnosing a Return to Healthy Profits
Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping...
516 Views
Prodia (PRDA IJ) - Back to Core Testing
Prodia (PRDA IJ) FY2022 results saw declines in revenues and profits but from a COVID-high base and the numbers are now well-above 2019, with...
459 Views
Prodia (PRDA IJ) - A Standout in Diagnostics
Prodia (PRDA IJ) stands out in terms of its strong market positioning and track record together with attractive valuations, especially versus...
328 Views
Prodia (PRDA IJ) - Going Digital with Precision
Prodia (PRDA IJ) remains one of our top healthcare picks in Indonesia, with rising health consciousness driving higher demand for testing....
628 Views
The Week That Was in ASEAN@Smartkarma - GoTo Completes, Ultrajaya's Milky Future, and BCA's Hybrid
The past week saw insights on GoTo (GOTO IJ), Ultrajaya Milk (ULTJ IJ), Bank Central Asia (BBCA IJ), Bank Negara Indonesia (BBNI IJ), and Bank...
308 Views